|
|
Bioadaptives Inc
BDPT's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Bioadaptives Inc 's sales fell
by -37.53 % in III. Quarter 2022 from the same quarter a year ago.
Ranking at No. 3326
Major Pharmaceutical Preparations industry recorded
growth of revenues by 0.82 %
• More on BDPT's Growth
|
|
Bioadaptives Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Bioadaptives Inc PEG ratio is at -0
|
| Company |
| |
|
PE TTM
|
| Industry |
|
0.01 |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.
• More on BDPT's Valuation
|
|
|
|
|
Bioadaptives Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Bioadaptives Inc PEG ratio is at -0
|
| Company |
| |
|
PE TTM
|
| Industry |
|
0.01 |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.
| | | |
